Back to Journals » Patient Preference and Adherence » Volume 16

Clinical Evaluation of Siponimod for the Treatment of Secondary Progressive Multiple Sclerosis: Pathophysiology, Efficacy, Safety, Patient Acceptability and Adherence

Total article views   HTML views PDF downloads Totals
10,320 Dovepress* 8,944+ 333 9,277
PubMed Central* 1,376 275 1,651
Totals 10,320 608 10,928
*Since 24 May 2022
Total mentioned Facebook Delicious Reddit Twitter Others
9 0 0 0 4 5

View citations on PubMed Central and Google Scholar